Eli Lilly arthritis drug gets FDA nod for emergency use with remdesivir to treat Covid-19 – CNBC

The U.S. Food and Drug Administration on Thursday approved the emergency use of Eli Lilly’s arthritis drug baricitinib, in combination with Gilead Sciences’ remdesivir, to treat Covid-19 patients.
B… [read more]

Leave a Reply